Michael J. Kamdar
Chief Executive Officer at Molecular Assemblies, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Banister | M | - |
Medipacs, Inc.
 Medipacs, Inc. Electronic Equipment/InstrumentsElectronic Technology Medipacs, Inc. develops infusion pump technology for fluid delivery systems. It offers Mini-Infuser CRI pump that is intended to be used for medication delivery, such as in post-surgical pain management, with 10-60 kg (22 lbs-130 lbs) canines that are under the supervised and direct care of veterinary healthcare professionals in a hospital or acute care setting. The company was founded in 2004 by Mark Banister and is headquartered in San Diego, CA. | 16 years |
| J. William Efcavitch | M | 68 |
Molecular Assemblies, Inc.
 Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA. | 11 years |
| Harry Allan George | M | 76 |
Medipacs, Inc.
Medipacs, Inc. Electronic Equipment/InstrumentsElectronic Technology Medipacs, Inc. develops infusion pump technology for fluid delivery systems. It offers Mini-Infuser CRI pump that is intended to be used for medication delivery, such as in post-surgical pain management, with 10-60 kg (22 lbs-130 lbs) canines that are under the supervised and direct care of veterinary healthcare professionals in a hospital or acute care setting. The company was founded in 2004 by Mark Banister and is headquartered in San Diego, CA. | - |
| John Nicols | M | 60 |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA. | 4 years |
| James E. Utts | M | 70 |
Medipacs, Inc.
Medipacs, Inc. Electronic Equipment/InstrumentsElectronic Technology Medipacs, Inc. develops infusion pump technology for fluid delivery systems. It offers Mini-Infuser CRI pump that is intended to be used for medication delivery, such as in post-surgical pain management, with 10-60 kg (22 lbs-130 lbs) canines that are under the supervised and direct care of veterinary healthcare professionals in a hospital or acute care setting. The company was founded in 2004 by Mark Banister and is headquartered in San Diego, CA. | - |
| Jeffrey Raikes | M | 66 |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA. | - |
| Larry G. Stambaugh | M | 77 |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA. | - |
| Helge Bastian | M | - |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA. | - |
| Mark Nibbe | M | - |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA. | 2 years |
| Arthur C. Pinto | M | - |
Medipacs, Inc.
Medipacs, Inc. Electronic Equipment/InstrumentsElectronic Technology Medipacs, Inc. develops infusion pump technology for fluid delivery systems. It offers Mini-Infuser CRI pump that is intended to be used for medication delivery, such as in post-surgical pain management, with 10-60 kg (22 lbs-130 lbs) canines that are under the supervised and direct care of veterinary healthcare professionals in a hospital or acute care setting. The company was founded in 2004 by Mark Banister and is headquartered in San Diego, CA. | - |
| Todd Peterson | M | 66 |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA. | - |
| Patrick Murphy | M | - |
Medipacs, Inc.
Medipacs, Inc. Electronic Equipment/InstrumentsElectronic Technology Medipacs, Inc. develops infusion pump technology for fluid delivery systems. It offers Mini-Infuser CRI pump that is intended to be used for medication delivery, such as in post-surgical pain management, with 10-60 kg (22 lbs-130 lbs) canines that are under the supervised and direct care of veterinary healthcare professionals in a hospital or acute care setting. The company was founded in 2004 by Mark Banister and is headquartered in San Diego, CA. | - |
| Wendy Berke | F | - |
Medipacs, Inc.
Medipacs, Inc. Electronic Equipment/InstrumentsElectronic Technology Medipacs, Inc. develops infusion pump technology for fluid delivery systems. It offers Mini-Infuser CRI pump that is intended to be used for medication delivery, such as in post-surgical pain management, with 10-60 kg (22 lbs-130 lbs) canines that are under the supervised and direct care of veterinary healthcare professionals in a hospital or acute care setting. The company was founded in 2004 by Mark Banister and is headquartered in San Diego, CA. | - |
| Hallie Kuhn | M | - |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA. | - |
| Jeffrey R. Sampson | M | - |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Slover | M | 49 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 8 years |
| Marios Fotiadis | M | 51 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 9 years |
| Elizabeth Reed | F | 53 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 11 years |
| Siegfried Reich | M | 64 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 13 years |
| Peter Johnson | M | 78 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 16 years |
| Stephen Worland | M | 66 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 13 years |
| Steven Holtzman | M | 70 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 7 years |
| George Scangos | M | 76 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 7 years |
| Colin E. Rowlings | M | - |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 4 years |
| Douglas Williams | M | 66 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 5 years |
| Neil James Clendeninn | M | 74 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 8 years |
| James R. Thomas | M | 73 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 2 years |
| Carmine Stengone | M | 48 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 2 years |
| James R. Appleman | M | 67 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | - |
| Mahnaz Ebrahimi | F | 67 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 11 years |
| Susie Melody | F | - |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 31 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael J. Kamdar
- Personal Network
